References:
1. World Health Organization. Rolling Updates on Coronavirus disease (COVID-19). World Health Oraganization. [Online] World Health Organization, December 31, 2019. [Cited: April 06, 2020.] https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
2. Worldometer. COVID-19 Coronavirus Pandemic. Worldometer. [Online] Worldometer, April 06, 2020. [Cited: April 06, 2020.] https://www.worldometers.info/coronavirus/.
3. Niforatos JD, Melnick ER, Faust JS. Covid-19 fatality is likely overestimated. BMJ. 2020 Mar 20;368:m1113. doi: 10.1136/bmj.m1113.
4. Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. 2020, Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742. doi:10.1016/j.antiviral.
5. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z,Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. [Epub ahead of print] doi: 10.1016/S2213-2600(20)30079-5.
6. Chen C., Zhang X.R., Ju Z.Y., He W.F. Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies. Chin. J. Burns. Zhonghua Shao Shang Za Zhi. 2020 Mar 1;36(0):E005. doi: 10.3760/cma.j.cn501120-20200224-00088, Vol. 36. E005.
7. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print].
8. Beigelman A, Bacharier LB, Baty J, Buller R, Mason S, Schechtman KB, Sajol G, Isaacson-Schmid M, Castro M, Storch GA. Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis? J Allergy Clin Immunol. 2015;136(4):1129–1131. doi:10.1016/j.jaci.2015.06.011.
9. Zhao Q, Tensfeldt TG, Chandra R, Mould DR. Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets. Malar J. 2014 Jan 29;13:36. doi: 10.1186/1475-2875-13-36.
10. Li Y, Bai WZ, Hashikawa T. J. Response to Commentary on: ”The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients”. Med Virol. 2020 Apr 4. doi: 10.1002/jmv.25824. [Epub ahead of print].
11. Dodd RY, Stramer SL. COVID-19 and Blood Safety: Help with a Dilemma. Transfus Med Rev. 2020 Feb 26. pii: S0887-7963(20)30015-8. doi: 10.1016/j.tmrv.2020.02.004. [Epub ahead of print].
12. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
13. Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ. Beneficial actions of melatonin in the management of viral infections: a new use for this ”molecular handyman”? Rev Med Virol. 2012 Sep;22(5):323-38, Vol. 22, pp. 323-38.
14. Silvestri M, Rossi GA. Melatonin: its possible role in the management of viral infections–a brief review. Ital J Pediatr 2013, Vol. 39, p. 61.
15. Vielma JR, Bonilla E, Chacín-Bonilla L, Mora M, Medina-Leendertz S, Bravo Y. Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review. Acta Trop 2014, Vol. 137, pp. 31-8.
16. Habtemariam S, Daglia M, Sureda A, Selamoglu Z, Gulhan MF, Nabavi SM. Melatonin and Respiratory Diseases: A Review. Curr Top Med Chem 2017, Vol. 17, pp. 467-488.
17. Srinivasan V, Mohamed M, Kato H. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat. Endocr. Metab. Immune Drug Discov, 2012, Vol. 6, pp. 30–39.
18. Tan DX, Korkmaz A, Reiter RJ, Manchester LC. Ebola virus disease: potential use of melatonin as a treatment. J. Pineal Res. 2014 Vol. 57, pp. 381–384.
19. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res. 2007 Vol. 42, pp. 28–42.
20. Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin’s metabolites, AFMK and AMK. J. Pineal Res. 2013 Vol. 54, pp. 245–257.
21. Bolmatov D, McClintic WT, Taylor G, Stanley CB, Do C, Collier CP, Leonenko Z, Lavrentovich MO, Katsaras J. Deciphering Melatonin-Stabilized Phase Separation in Phospholipid Bilayers. Langmuir. 2019, Vol. 35, pp. 12236-12245.
22. Gitto E, Reiter RJ, Amodio A, Romeo C, Cuzzocrea E, Sabatino G, et al. Early indicators of chronic lung disease in infant with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res. 2005 Vol. 39, pp. 287-93.
23. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi S, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001, Vol. 50, pp. 756-60.
24. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in critically ill patients : Encouraging results from a small randomized controlled trial. Crit Care. 2008, Vol. 12, p. R52.
25. Valero N, Mosquera J, Alcocer S, Bonilla E, Salazar J, Álvarez-Mon M. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis. Brain Res. 2015 Oct 5;1622:368-76. doi: 10.1016/j.brainres.2015.06.034. Epub 2015 Jul 10.
26. Hung SW. Minocycline-induced acute eosinophilic pneumonia: A case report and review of the literature. Respir Med Case Rep. 2015 May 30;15:110-4. doi: 10.1016/j.rmcr.2015.05.013. eCollection 2015.
27. Midgley CM, and The COVID-19 Investigation Team. First 12 patients with coronavirus disease 2019 (COVID-19) in the United States. [Online] [Cited: April 06, 2020.] https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1.full.pdf.
28. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov, 2020 Vol. 6, p. 14.